ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biobased Chemicals

Biobased chemical developer Genomatica raises another $90 million

by Michael McCoy
October 7, 2018 | APPEARED IN VOLUME 96, ISSUE 40

The biobased chemical developer Genomatica has raised $90 million in its latest round of fundraising. Among the firm’s investors is Ginkgo Bioworks, a synthetic biology company that is expanding its research pact with Genomatica. Genomatica takes credit for two commercial processes: The Italian firm Novamont uses its technology in a 1,4-butanediol plant that opened in 2016, and Genomatica markets its own product, 1,3-butanediol, to the cosmetics industry.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment